Cethromycin-d₆

[1]. Hammerschlag MR, et al. Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections. Expert opinion on investigational drugs. 2008 Mar;17(3):387-400.

[2]. Pavlović D, et al. Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity. ACS medicinal chemistry letters. 2011 May 12;2(5):331-6.

[3]. Sullivan DJ, et al. Discovery of Novel Liver-Stage Antimalarials through Quantum Similarity. PLoS One. 2015 May 7;10(5):e0125593.

[4]. Bosnar M, et al. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrobial agents and chemotherapy. 2005 Jun;49(6):2372-7.

[5]. Parnham MJ. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr Opin Infect Dis. 2005 Apr;18(2):125-31.

[6]. Kim MK, et al. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. Antimicrobial agents and chemotherapy. 2002 Oct;46(10):3185-92.

[7]. Hu Y, et al. The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin. BMC microbiology. 2023 Apr 20;23(1):109. [Content Brief]

[8]. Kennedy G, et al. Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages. Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0021525.

[9]. Ríos AM, et al. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrobial agents and chemotherapy. 2004 Aug;48(8):2897-904.

[10]. Xuan D, et al. Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach. J Pharm Pharmacol. 2002 Jan;54(1):71-5.